(Q71860102)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605865%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605865%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

1 reference

1 reference

1 reference

Helicobacter pylori infectious disease

1 reference

M. M. Yousfi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7605865

10 June 2024

H. M. el-Zimaity

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7605865

10 June 2024

M. T. al-Assi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7605865

10 June 2024

R. A. Cole

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7605865

10 June 2024

R. M. Genta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7605865

10 June 2024

D. Y. Graham

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7605865

10 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7605865

10 June 2024

publication date

1 April 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605865%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.1995.tb00374.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2036.1995.tb00374.x

10 June 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

Alimentary Pharmacology & Therapeutics

10 June 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605865%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605865%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605865%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

209-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605865%20AND%20SRC:MED&resulttype=core&format=json

Drug therapy for Helicobacter pylori infection: problems and pitfalls

21 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease

10 June 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

Helicobacter pylori and metronidazole resistance

10 June 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate

10 June 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

Metronidazole-resistant Helicobacter pylori

10 June 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination

10 June 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones.

10 June 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics

10 June 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

Eradication of Helicobacter pylori with clarithromycin and omeprazole

10 June 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

Omeprazole, bismuth and clarithromycin in the sequential treatment of Helicobacter pylori infection

10 June 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

Clarithromycin-amoxycillin therapy for Helicobacter pylori infection

10 June 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

Clarithromycin and omeprazole for Helicobacter pylori

10 June 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain.

10 June 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

In vivo susceptibility of Campylobacter pylori

10 June 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

Prevalence of metronidazole-resistant Helicobacter pylori in dyspeptic patients.

10 June 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection.

10 June 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00374.X

10 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605865%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference